Perinatal Hepatitis B Prevention Program
The Perinatal Hepatitis B Prevention Program (PHBPP) was created because Congress recognized the need to foster efforts to prevent perinatal HBV transmission and made resources available to develop and implement programs. CDC annually awards funds to support perinatal hepatitis B prevention programs among 64 immunization grantees. The mission of these programs is the prevention of hepatitis B transmission from infected mothers to infants through the identification of hepatitis B surface antigen (HBsAg)-positive pregnant women and their infants and the case management of the infants and household and sexual contacts.
The goals of the PHBPP are to (1) identify HBsAg-positive pregnant women, (2) identify and manage infants born to HBsAg-positive mothers and to mothers without HBsAg test results until maternal status is determined, (3) insure that delivery hospitals administer recommended post-exposure prophylaxis (hepatitis B immune globulin HBIG and hepatitis B vaccine), and (4) insure infants complete the hepatitis B vaccine series and receive post-vaccination testing.
Smith EA, Jacques-Carroll L, Walker TY, Sirotkin B, Murphy TV. The National Perinatal Hepatitis B Prevention Program, 1994-2008. Pediatrics 2012 Apr;129(4):609-16. doi: 10.1542/peds.2011-2866. Epub 2012 Mar 26.
CDC. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth – United States, 2008-2011. MMWR 2012;61(38):768-71.